This medicine is used for the following purposes:
- skin discoloration
- skin rash
Brand Name(s): Opzelura
Generic Name: Ruxolitinib
Instructions
DO NOT take this medicine by mouth.
Apply a thin layer to the affected area and rub it in.
Do not cover the treated area with a bandage unless your doctor instructs you to do so.
Keep the medicine at room temperature. Avoid heat and direct light.
This medicine should only be used on the skin.
Avoid using on open wounds or infected areas.
Wash your hands before and after handling this medicine.
Wash your hands after using this medicine unless your hands are part of the area being treated.
Do not touch your eyes, nose or mouth after handling the medicine.
If medicine gets in your eyes, rinse well with cool water.
If your doctor recommends a moisturizer, apply it after using this medicine.
Drug interactions can change how medicines work or increase risk for side effects. Tell your health care providers about all medicines taken. Include prescription and over-the-counter medicines, vitamins, and herbal medicines. Speak with your doctor or pharmacist before starting or stopping any medicine.
Keep all appointments for medical exams and tests while on this medicine.
Cautions
This medicine may increase the risk of cancer. Ask your doctor about the benefits and risks.
This medicine is associated with an increased risk of blood clots, heart attack, and stroke. Contact your doctor immediately if you experience leg pain or swelling, difficulty breathing, chest or jaw pain, severe headache, one-sided weakness or slurred speech.
Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine.
Do not use the medication any more than instructed.
This medicine may reduce your body's ability to fight infections. Avoid contact with people with colds, flu or other infections. Contact your doctor if you develop fever, cough, sore throat, or chills.
Do not breastfeed while on this medicine. You may safely start breastfeeding 4 weeks after stopping treatment.
During pregnancy, this medicine should be used only when clearly needed. Talk to your doctor about the risks and benefits.
If you forget to take a dose on time, take it as soon as you remember. If it is almost time for the next dose, do not take the missed dose. Return to your normal schedule. Do not take 2 doses at one time.
Do not share this medicine with anyone who has not been prescribed this medicine.
Contact your doctor if your symptoms do not get better or if they get worse after using this medicine for 8 weeks, if treating eczema, or for 24 weeks, if treating vitiligo.
Side Effects
Call your doctor or get medical help right away if you notice any of these more serious side effects:
- bleeding or bruising
- chest pain
- fainting
- fever or chills
- sudden leg pain, swelling, warmth or redness
- pale or blue skin, lips or fingernails
- rapid breathing
- shortness of breath
- unusual changes or growths on skin
- symptoms of stroke (such as one-sided weakness, slurred speech, confusion)
- excessive or unusual sweating
- unusual or unexplained tiredness or weakness
A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.
Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.
IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all there is to know about it. Your doctor or pharmacist may give you other documents about your medicine. Please talk to them if you have any questions. Always follow their advice.
There is a more complete description of this medicine available in English. Scan this code on your smartphone or tablet or use the web address below. You can also ask your pharmacist for a printout. If you have any questions, please ask your pharmacist.
The display and use of this drug information is subject to Terms of Use.
More information about RUXOLITINIB - TOPICAL
Copyright(c) 2024 First Databank, Inc.
Selected from data included with permission and copyright by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
Conditions of Use: The information in this database is intended to supplement, not substitute for the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. The display and use of this drug information is subject to express Terms of Use.
